Case Control Study
Copyright ©The Author(s) 2024.
World J Hepatol. May 27, 2024; 16(5): 784-790
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.784
Table 2 Procedural outcomes of cirrhotic and non-cirrhotic cohorts, n (%)

Cirrhosis (16 patients, 19 procedures)
Controls (43 patients, 45 procedures)
P value
Primary outcomes
En bloc resection16 (84.21)40 (88.89)0.61
R0 resection15 (78.94)31 (68.89)0.41
Curative resection14 (73.68)29 (64.44)0.47
Procedure duration (mean ± SD; min)89.32 ± 40.6197.62 ± 57.30.52
Follow-up10 (52.63)19 (42.22)0.44
Recurrence4 (40)1 (5.26)0.019
Adverse events
Any adverse event4 (21.05)5 (12.5)0.30
Surgery for any cause2 (10.52)4 (9.76)0.83
Admitted7 (36.84)26 (57.78)0.13
Pneumoperitoneum/pneumomediastinum1 (5.26)2 (4.44)0.89
Micro-perforation01 (2.22)1.00
Delayed bleeding (yes)1 (5.26)5 (11.11)0.46
Procedural characteristics
Closure (yes)12 (63.16)21 (46.67)0.23
Use of traction (yes)1 (5.26)3 (6.67)0.83
Use of a stabilization device (yes)4 (21.05)3 (6.67)0.09
Use of coagrasper (yes)9 (47.37)9 (20)0.026
Coagrasper use by location
Colorectal3 (60)00.012
Stomach2 (66.66)2 (33.33)0.34
Esophagus4 (40)7 (29.17)0.54
Duodenum00